| UniProt ID | GO45_HUMAN | |
|---|---|---|
| UniProt AC | Q9H2G9 | |
| Protein Name | Golgin-45 | |
| Gene Name | BLZF1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 400 | |
| Subcellular Localization |
Golgi apparatus lumen . Isoform 1: Nucleus. Isoform 2: Cytoplasm. |
|
| Protein Description | Required for normal Golgi structure and for protein transport from the endoplasmic reticulum (ER) through the Golgi apparatus to the cell surface.. | |
| Protein Sequence | MTTKNLETKVTVTSSPIRGAGDGMETEEPPKSVEVTSGVQSRKHHSLQSPWKKAVPSESPGVLQLGKMLTEKAMEVKAVRILVPKAAITHDIPNKNTKVKSLGHHKGEFLGQSEGVIEPNKELSEVKNVLEKLKNSERRLLQDKEGLSNQLRVQTEVNRELKKLLVASVGDDLQYHFERLAREKNQLILENEALGRNTAQLSEQLERMSIQCDVWRSKFLASRVMADELTNSRAALQRQNRDAHGAIQDLLSEREQFRQEMIATQKLLEELLVSLQWGREQTYSPSVQPHSTAELALTNHKLAKAVNSHLLGNVGINNQKKIPSTVEFCSTPAEKMAETVLRILDPVTCKESSPDNPFFESSPTTLLATKKNIGRFHPYTRYENITFNCCNHCRGELIAL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTTKNLETK ------CCCCCCEEE | 46.61 | 29449344 | |
| 3 | Phosphorylation | -----MTTKNLETKV -----CCCCCCEEEE | 19.35 | 29449344 | |
| 4 | Ubiquitination | ----MTTKNLETKVT ----CCCCCCEEEEE | 50.82 | 33845483 | |
| 8 | Phosphorylation | MTTKNLETKVTVTSS CCCCCCEEEEEEECC | 33.70 | 29449344 | |
| 11 | Phosphorylation | KNLETKVTVTSSPIR CCCEEEEEEECCCCC | 21.44 | 28450419 | |
| 13 | Phosphorylation | LETKVTVTSSPIRGA CEEEEEEECCCCCCC | 17.70 | 28102081 | |
| 14 | Phosphorylation | ETKVTVTSSPIRGAG EEEEEEECCCCCCCC | 29.76 | 30266825 | |
| 15 | Phosphorylation | TKVTVTSSPIRGAGD EEEEEECCCCCCCCC | 18.25 | 30266825 | |
| 26 | Phosphorylation | GAGDGMETEEPPKSV CCCCCCCCCCCCCCE | 36.43 | 20068231 | |
| 31 | Ubiquitination | METEEPPKSVEVTSG CCCCCCCCCEEECCC | 77.25 | 21906983 | |
| 31 (in isoform 1) | Ubiquitination | - | 77.25 | 21906983 | |
| 31 (in isoform 2) | Ubiquitination | - | 77.25 | 21906983 | |
| 32 | Phosphorylation | ETEEPPKSVEVTSGV CCCCCCCCEEECCCC | 29.32 | 25159151 | |
| 37 | Phosphorylation | PKSVEVTSGVQSRKH CCCEEECCCCCCCCC | 41.99 | - | |
| 43 | Ubiquitination | TSGVQSRKHHSLQSP CCCCCCCCCCCCCCC | 51.41 | 29967540 | |
| 49 | Phosphorylation | RKHHSLQSPWKKAVP CCCCCCCCCHHHCCC | 37.71 | 20068231 | |
| 52 | Ubiquitination | HSLQSPWKKAVPSES CCCCCCHHHCCCCCC | 33.95 | 29967540 | |
| 59 | Phosphorylation | KKAVPSESPGVLQLG HHCCCCCCCCHHHHH | 31.15 | 25159151 | |
| 67 | Ubiquitination | PGVLQLGKMLTEKAM CCHHHHHHHHHHHHH | 39.05 | 21906983 | |
| 67 (in isoform 2) | Ubiquitination | - | 39.05 | 21906983 | |
| 67 (in isoform 1) | Ubiquitination | - | 39.05 | 21906983 | |
| 70 | Phosphorylation | LQLGKMLTEKAMEVK HHHHHHHHHHHHHHC | 31.76 | - | |
| 72 (in isoform 1) | Ubiquitination | - | 48.04 | 21906983 | |
| 72 (in isoform 2) | Ubiquitination | - | 48.04 | 21906983 | |
| 72 | Ubiquitination | LGKMLTEKAMEVKAV HHHHHHHHHHHHCEE | 48.04 | 21906983 | |
| 77 | Sumoylation | TEKAMEVKAVRILVP HHHHHHHCEEEEEEE | 28.05 | - | |
| 77 | Sumoylation | TEKAMEVKAVRILVP HHHHHHHCEEEEEEE | 28.05 | - | |
| 77 | Ubiquitination | TEKAMEVKAVRILVP HHHHHHHCEEEEEEE | 28.05 | 22817900 | |
| 85 | Ubiquitination | AVRILVPKAAITHDI EEEEEEEHHHHCCCC | 42.86 | 33845483 | |
| 95 | Ubiquitination | ITHDIPNKNTKVKSL HCCCCCCCCCCCEEC | 61.72 | 29967540 | |
| 106 (in isoform 1) | Ubiquitination | - | 55.23 | 21906983 | |
| 106 (in isoform 2) | Ubiquitination | - | 55.23 | 21906983 | |
| 106 | Ubiquitination | VKSLGHHKGEFLGQS CEECCCCCCCHHCCC | 55.23 | 21906983 | |
| 121 | Ubiquitination | EGVIEPNKELSEVKN CCCCCCCHHHHHHHH | 71.41 | 29967540 | |
| 127 | Ubiquitination | NKELSEVKNVLEKLK CHHHHHHHHHHHHHH | 36.97 | 29967540 | |
| 127 | Sumoylation | NKELSEVKNVLEKLK CHHHHHHHHHHHHHH | 36.97 | - | |
| 127 | Sumoylation | NKELSEVKNVLEKLK CHHHHHHHHHHHHHH | 36.97 | - | |
| 144 | Ubiquitination | ERRLLQDKEGLSNQL HHHHHHCHHHHCHHH | 40.49 | 23503661 | |
| 144 (in isoform 2) | Ubiquitination | - | 40.49 | - | |
| 156 | Ubiquitination | NQLRVQTEVNRELKK HHHHHHHHHHHHHHH | 22.24 | 21963094 | |
| 176 | Ubiquitination | VGDDLQYHFERLARE HCHHHHHHHHHHHHH | 12.72 | 22817900 | |
| 177 | Ubiquitination | GDDLQYHFERLAREK CHHHHHHHHHHHHHH | 5.07 | 22817900 | |
| 184 | Ubiquitination | FERLAREKNQLILEN HHHHHHHHCHHHHCC | 44.43 | 29967540 | |
| 184 | 2-Hydroxyisobutyrylation | FERLAREKNQLILEN HHHHHHHHCHHHHCC | 44.43 | - | |
| 198 | Phosphorylation | NEALGRNTAQLSEQL CCCCCCCHHHHHHHH | 17.89 | 22210691 | |
| 222 | Phosphorylation | WRSKFLASRVMADEL HHHHHHHHHHHHHHH | 27.79 | 29083192 | |
| 230 | Phosphorylation | RVMADELTNSRAALQ HHHHHHHHHHHHHHH | 29.15 | 29083192 | |
| 232 | Phosphorylation | MADELTNSRAALQRQ HHHHHHHHHHHHHHH | 20.33 | 29083192 | |
| 282 | Phosphorylation | LQWGREQTYSPSVQP HHHCCCCCCCCCCCC | 22.63 | 29214152 | |
| 283 | Phosphorylation | QWGREQTYSPSVQPH HHCCCCCCCCCCCCC | 20.48 | 20068231 | |
| 284 | Phosphorylation | WGREQTYSPSVQPHS HCCCCCCCCCCCCCC | 17.68 | 29496963 | |
| 286 | Phosphorylation | REQTYSPSVQPHSTA CCCCCCCCCCCCCHH | 27.69 | 20068231 | |
| 304 | Ubiquitination | LTNHKLAKAVNSHLL HCHHHHHHHHHHHHH | 64.40 | 29967540 | |
| 320 | Ubiquitination | NVGINNQKKIPSTVE CCCCCCCCCCCCCCE | 55.59 | 29967540 | |
| 321 | Ubiquitination | VGINNQKKIPSTVEF CCCCCCCCCCCCCEE | 50.51 | 29967540 | |
| 324 | Phosphorylation | NNQKKIPSTVEFCST CCCCCCCCCCEECCC | 48.86 | 28857561 | |
| 325 | Phosphorylation | NQKKIPSTVEFCSTP CCCCCCCCCEECCCH | 20.78 | 28857561 | |
| 330 | Phosphorylation | PSTVEFCSTPAEKMA CCCCEECCCHHHHHH | 42.62 | 28555341 | |
| 331 | Phosphorylation | STVEFCSTPAEKMAE CCCEECCCHHHHHHH | 27.91 | 21815630 | |
| 339 | Phosphorylation | PAEKMAETVLRILDP HHHHHHHHHHHHHCC | 18.46 | 22210691 | |
| 348 | Phosphorylation | LRILDPVTCKESSPD HHHHCCCCCCCCCCC | 24.21 | 18669648 | |
| 350 | Ubiquitination | ILDPVTCKESSPDNP HHCCCCCCCCCCCCC | 51.79 | 21963094 | |
| 352 | Phosphorylation | DPVTCKESSPDNPFF CCCCCCCCCCCCCCC | 32.44 | 22199227 | |
| 353 | Phosphorylation | PVTCKESSPDNPFFE CCCCCCCCCCCCCCC | 37.05 | 26055452 | |
| 361 | Phosphorylation | PDNPFFESSPTTLLA CCCCCCCCCCCEEEE | 36.14 | 25850435 | |
| 362 | Phosphorylation | DNPFFESSPTTLLAT CCCCCCCCCCEEEEE | 21.04 | 26055452 | |
| 364 | Phosphorylation | PFFESSPTTLLATKK CCCCCCCCEEEEECC | 31.83 | 22199227 | |
| 365 | Phosphorylation | FFESSPTTLLATKKN CCCCCCCEEEEECCC | 24.14 | 22199227 | |
| 369 | Phosphorylation | SPTTLLATKKNIGRF CCCEEEEECCCCCCC | 42.39 | 18669648 | |
| 370 (in isoform 1) | Ubiquitination | - | 37.91 | 21906983 | |
| 370 | Ubiquitination | PTTLLATKKNIGRFH CCEEEEECCCCCCCC | 37.91 | 22817900 | |
| 371 | Ubiquitination | TTLLATKKNIGRFHP CEEEEECCCCCCCCC | 49.82 | 22817900 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GO45_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GO45_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-353 AND THR-369, ANDMASS SPECTROMETRY. | |